Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL48360 | 1.00 | GPR35 (0.53) | GPR35TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL3206927 | 0.88 | GPR35 (0.55) | GPR35TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL48359 | 0.88 | GPR35 (0.55) | GPR35TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL11250446 | 0.87 | GPR35 (0.50) | GPR35TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL11250442 | 0.87 | GPR35 (0.50) | GPR35TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL17005575 | 0.85 | TSHR (0.51) | GPR35TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL1652615 | 0.85 | GPR35 (0.51) | GPR35TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL2373772 | 0.85 | GPR35 (0.51) | GPR35TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL57737 | 0.84 | ALDH1A1 (0.58) | ALDH1A1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL57738 | 0.84 | ALDH1A1 (0.58) | ALDH1A1MEN1KMT2ATDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114094175-A | Secondary battery | 珠海冠宇电池股份有限公司 | 2022-02-25 | — | — | CN | claimed |
| EP-2570416-B1 | Antiviral bisfuran derivative as hiv protease inhibitor and intermediates thereof | GILEAD SCIENCES INC (US) | 2016-03-16 | — | — | EP | claimed |
| EP-1999133-B1 | PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS | GILEAD SCIENCES INC (US) | 2013-08-21 | — | — | EP | claimed |
| US-20130172295-A1 | PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2013-07-04 | — | — | US | claimed |
| US-8445734-B2 | Photolabile protective groups for improved processes to prepare oligonucleotide arrays | NIGU CHEMIE GMBH (DE) | 2013-05-21 | — | — | US | claimed |
| EP-2570416-A1 | Antiviral bisfuran derivative as hiv protease inhibitor and intermediates thereof | Gilead Sciences, Inc. (US) | 2013-03-20 | — | — | EP | claimed |
| US-8173623-B2 | Process for preparation of HIV protease inhibitors | GILEAD SCIENCES, INC. (US) | 2012-05-08 | — | — | US | claimed |
| US-20110065631-A1 | PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS | GILEAD SCIENCES, INC (US) | 2011-03-17 | — | — | US | claimed |
| US-20080004242-A1 | Process for preparation of HIV protease inhibitors | GILEAD SCIENCES, INC. | 2008-01-03 | — | — | US | claimed |
| EP-1134248-B1 | Process for the preparation of polycarbonate diols with a high molecular weight | POLIMERI EUROPA SPA (IT) | 2005-08-03 | — | — | EP | claimed |
| US-6384178-B2 | COMPRISING TWO SUBSEQUENT REACTION STEPS, WHEREIN IN FIRST STEP POLYCARBONATE DIOL WITH MOLECULAR WEIGHT OF 500 TO 2000 IS SYNTHESIZED AND IN SECOND STEP MOLECULAR WEIGHT OF POLYCARBONATE DIOL IS INCREASED | ENICHEM S.P.A. (IT) | 2002-05-07 | — | — | US | claimed |
| US-20010047073-A1 | Process for the preparation of polycarbonate diols with a high molecular weight | ENICHEM S.P.A. (IT) | 2001-11-29 | — | — | US | claimed |
| EP-1134248-A1 | Process for the preparation of polycarbonate diols with a high molecular weight | Enichem S.p.A. (IT) | 2001-09-19 | — | — | EP | claimed |
| US-5446134-A | Reacting bis(fluorosulfonyl)methane salt with cyanogen halide or pseudohalide | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1995-08-29 | — | — | US | claimed |
| US-20250281634-A1 | CONJUGATES COMPRISING A PHOSPHORUS (V) AND A DRUG MOIETY | TUBULIS GMBH (DE) | 2025-09-11 | — | — | US | disclosed |
| EP-4554984-A1 | MANNOSYLATED AMINE DEXTRAN DRUG DELIVERY VEHICLES WITH DEGRADABLE DISULFIDE/CARBONATE LINKERS TARGETING PAYLOADS TO CD206 EXPRESSING CELLS | Navidea Biopharmaceuticals, Inc. (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025072355-A1 | METHODS FOR AND COMPOSITIONS OF NON-PEG BIOCONJUGATES WITH ULTRA-HIGH DRUG-TO-AGENT RATIO | BIOHYBRID SOLUTIONS HOLDINGS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-1995015352-A1 | ALBUMIN BASED HYDROGEL | UNIVERSITE DU QUEBEC A MONTREAL (CA) | 1995-06-08 | — | — | WO | disclosed |
| EP-0410214-B1 | PROCESS FOR THE PREPARATION OF N,N-DISUBSTITUTED MONO- AND OLIGOURETHANES | BAYER AG (DE) | 1993-08-18 | — | — | EP | disclosed |
| US-5221798-A | Changing the regiopurity of mixtures containing 4,4'-disubstituted diphenyl carbonates | AMOCO CORPORATION (US) | 1993-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250281634-A1 | CONJUGATES COMPRISING A PHOSPHORUS (V) AND A DRUG MOIETY | CALCR, BCR, PTH1R | GPR35 487/4885TSHR 214/4885ALDH1A1 1805/4885 |
| US-20130172295-A1 | PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS | PRSS1, PREP, SERPINB1 | GPR35 4829/4885TSHR 4789/4885ALDH1A1 2742/4885 |
| US-20110065631-A1 | PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS | PREP, PRSS1, SERPINB1 | GPR35 4825/4885TSHR 4819/4885ALDH1A1 1261/4885 |
| US-20080004242-A1 | Process for preparation of HIV protease inhibitors | PRSS1, PREP, SERPINB1 | GPR35 4829/4885TSHR 4789/4885ALDH1A1 2742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.